Yoko Nishimura

Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study

Aya Narita, Kentarou Shirai, Shinji Itamura et al. · Annals of Clinical and Translational Neurology · 2016 · 215 citations · Full text

Medicine, Neurology, Pharmacology +13

Plasma miR‐208 as a useful biomarker for drug‐induced cardiotoxicity in rats

Yoko Nishimura, Chiaki Kondo, Yuji Morikawa et al. · Journal of Applied Toxicology · 2014 · 90 citations

Medicine, Pharmacology, Toxicology +17

Biomarker panel of cardiac and skeletal muscle troponins, fatty acid binding protein 3 and myosin light chain 3 for the accurate diagnosis of cardiotoxicity and musculoskeletal toxicity in rats

Yutaka Tonomura, Shuuichi Matsushima, Emi Kashiwagi et al. · Toxicology · 2012 · 62 citations

Life Sciences, Physiology, Toxicology +15

De novo ATP1A3 variants cause polymicrogyria

Satoko Miyatake, Mitsuhiro Kato, Takuma Kumamoto et al. · Science Advances · 2021 · 30 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Accelerated declining tendency of human T-cell leukemia virus type I carrier rates among younger blood donors in Kumamoto, Japan.

S Oguma, Yoichi Imamura, Yukihiko Kusumoto et al. · PubMed · 1992 · 24 citations

Public Health, Infectious Diseases, Population Health Sciences +8